[1] 罗时和. 北京油鸡. 农业知识, 2008, (8): 46.
[2] 马月辉, 徐桂芳, 王端云, 刘海良. 中国畜禽遗传资源信息动态研究. 中国农业科学, 2002, 35(5): 552-555.
[3] 陈幼春, 马月辉, 何晓红, 浦亚斌. 地方、培育、引入品种资源的保存与发展的研究进展. 中国畜牧兽医, 2008, 35(1): 5-11.
[4] 刘刚. 国家级畜禽遗传资源保护名录. 四川农业科技, 2007, (5): 42.
[5] Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation, 1968, 6(2): 230-247.
[6] 王恒湘, 郭子宽. 间充质干细胞在组织再生应用中的诸多问题. 组织工程与重建外科杂志, 2008, 4(5): 241-245.
[7] Jenkins N. Animal cell biotechnology: Methods and protocols. New Jersey: Humana Press, 1999: 132-138.
[8] Tan J, Liu T, Hou L, Meng WT, Wang YC, Zhi W, Deng L. Maintenance and expansion of hematopoietic stem/progenitor cells in biomimetic osteoblast niche. Cytotechnology, 2010, 62(5): 439-448.
[9] Honmou O, Houkin K, Matsunaga T, Niitsu Y, Ishiai S, Onodera R, Waxman SG, Kocsis JD. Intravenous admini-stration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain, 2011, 134(6): 1790-1807.
[10] 周向梅, 马月辉, 关伟军, 文杰, 李晗. 北京油鸡胚胎成纤维细胞系建立与生物学特性研究. 畜牧兽医学报, 2005, 36(3): 209-215.
[11] Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Brit J Haematol, 2000, 109(1): 235-242.
[12] Seong JM, Kim BC, Park JH, Kwon K II, Mantalaris A, Hwang YS. Stem cells in bone tissue engineering. Biomed Mater, 2010, 5(6): 062001.
[13] Girdlestone J, Limbani VA, Cutler AJ, Navarrete CV. Efficient expansion of mesenchymal stromal cells from um-bilical cord under low serum conditions. Cytotherapy, 2009, 11(6): 738-748.
[14] 刘伟, 刘萌, 祝劲松, 郝红伟, 董宁征, 周海滨. 人骨髓间充质干细胞的体外培养、鉴定及成骨分化. 中国组织工程研究, 2102, 16(14): 2515-2519.
[15] Birmingham E, Niebur GL, McHugh PE, Shaw G, Barry FP, McNamara LM. Osteogenic differentiation of mesenchymal stem cells is regulated by osteocyte and osteoblast cells in a simplified bone niche. Eur Cell Mater, 2012, 12(23): 13-27.
[16] 余卫, 张洹, 何冬梅. 体外诱导小鼠胎肝间充质干细胞向胰岛B样细胞分化的研究. 第二军医大学学报, 2004, 25(8): 827-830.
[17] Haasters F, Prall WC, Anz D, Bourquin C, Pautke C, Endres S, Mutschler W, Docheva D, Schieker M. Mor-phological and immunocytochemical characteristics indi-cate the yield of early progenitors and represent a quality control for human mesenchymal stem cell culturing. J Anat, 2009, 214(5): 759-767.
[18] Colter DC, Class R, DiGirolamo CM, Prockop DJ. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA, 2000, 97(7): 3213-3218.
[19] Morikawa S, Mabuchi Y, Kubota Y, Nagai Y, Niibe K, Hiratsu E, Suzuki S, Miyauchi-Hara C, Nagoshi N, Sunabori T, Shimmura S, Miyawaki A, Nakagawa T, Suda T, Okano H, Matsuzaki Y. Prospective identification, iso-lation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med, 2009, 206(11): 2483-2496.
[20] 郭子宽. 间充质干细胞及其临床应用中的几个问题. 中国组织工程研究, 2012, 16(1): 1-10.
[21] Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126(4): 663-676.
[22] Jiang RH, Han ZB, Zhou GS, Qu XD, Li X, Wang X, Shao YK, Yang SM, Han ZC. Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study. Front Med, 2011, 5(1): 94-100.
[23] Nakajima H, Uchida K, Guerrero AR, Watanabe S, Sugita D, Takeura N, Yoshida A, Long G, Wright KT, Johnson WE, Baba H. Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. J Neurotrauma, 2012, 29(8): 1614-1625.
